UK anti-migrant rhetoric actively harms the mental health of asylum seekers

Debate continues over whether uk anti-migrant rhetoric actively harms the mental health....

Overview Debates Related claims Topics Sources

Canada should exclude mental illness as a sole condition for medically assisted dying

Outro plans to use its $7 million in capital to expand its network of deprescribing clinicians and develop artificial intelligence clinical decision support tools.

Approximately one in six Americans take an antidepressant medication, and average duration of use has surpassed five years.

Outro's deprescribing platform incorporates personalized hyperbolic tapering plans, compounded medication doses, patient monitoring, and specially-trained clinicians.

Outro plans to expand its tapering model into additional medication classes beyond antidepressants, including benzodiazepines, gabapentinoids, and GLP-1s.

Research led by Dr. Mark Horowitz found that four in five long-term antidepressant users were unable to stop taking their medications due to withdrawal symptoms.

Hyperbolic tapering is the most effective protocol for discontinuing psychiatric medications

Commercial digital platforms are suitable for managing complex psychiatric drug withdrawal

U.S. healthcare providers should prioritize deprescribing over long-term psychiatric medication maintenance

FDA approval standards based on short-term trials adequately protect long-term antidepressant users

Victoria should launch targeted public health campaigns on cannabis risks for young women

Cannabis-related admissions create an unsustainable strain on Victoria's public health system

Cannabis consumption poses a severe public health risk through induced psychosis

A NHS report into mental health services following Suzanne Brown's killing identified eight failures, including a lack of risk assessments or professional monitoring after Jake Neate's clozapine was stopped.

A July 2026 letter from Jake Neate's doctor at Rampton hospital described his mental health disorder as very resistant to treatment despite overall progress and recent episodes of decline.

Outro's flagship Taper Management program for psychiatric medication deprescribing is available in 14 U.S. states.

Hyperbolic tapering is a methodology that gradually reduces medication dosage by progressively smaller amounts as the overall dose decreases.

The U.S. Department of Health and Human Services is collaborating with the American Psychiatric Association and the American Society of Clinical Psychopharmacology on deprescribing standards.

In 2026, the U.S. Department of Health and Human Services prioritized developing evidence-based deprescribing guidelines to curb psychiatric overprescribing.

Deprescribing protocols are largely absent from U.S. medical training, leaving clinicians and patients without formal guidance for stopping psychiatric medications.